Subscribe to our newsletter

VisiVite needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at anytime.

Recent Articles

More like this

Crying Human Tear Glands Grown in Lab

With the goal of trying to develop new therapies for patients suffering from an inability to produce enough tears as well understanding cancers of the tear gland, researchers have successfully grown human tear glands that can actually cry.

High cholesterol levels associated with macular degeneration

A recent study published in Acta Ophtalmologica reveals that high serum cholesterol levels may be linked to an increased likelihood of developing age-related macular degeneration (AMD) later in life.

Cataract surgery decreases eye pressure in the short-term

Patients who are being treated with ocular hypotensive medications who undergo cataract surgery experience a short-term decrease in their intraocular pressure (IOP) and a long-term decrease in their medications according to results from the Ocular [...]

Protein Imbalance May Be Responsible for Cataracts

Researchers at the Technical University of Munich recently discovered that the composition of the protein solution within the eye's lens was a significant factor in the development of cataracts. 

Cataract patients happier when preop fasting is eliminated

The American Society of Anesthesiologists (ASA) guidelines were updated in 2011 to require fasting before undergoing general anesthesia to reduce the risk of aspiration pneumonia. However, fasting doesn't guarantee gastric emptying.

Deficiency in Vitamin B12 can cause vision problems

A deficiency in vitamin B12 leads to many health issues and one of those issues is damage to the nervous system including damage to the optic nerve. B12 deficiency disrupts the nervous signal traveling from the eye to the brain causing a condition [...]

New treatment for diabetic retinopathy enters Phase II Trial

REGENXBIO has announced the start of Phase II trial for its RGX-314 to treat chronic retinal conditions including diabetic retinopathy and wet macular degeneration. RGX-314 is administered via SCS Microinjector for targeted delivery of gene therapy [...]

Study shows a majority of diabetics failing to get regular eye exams

A large study conducted by the Wills Eye Hospital and the Centers for Disease Control and Prevention revealed that most diabetics do not have yearly eye exams despite being at an increased risk of developing serious eye diseases. 

FDA approves Eysuvis as Dry Eye Treatment

Kala Pharmaceutical announced that the Food and Drug Administration (FDA) has approved Eysuvis for the short-term treatment of dry eye syndrome. Unlike other prescription therapies, Eysuvis is a corticosteroid, Corticosterioids are commonly used as [...]
More recent articles

Ultimate insiders Guide to Eye Health

Newly updated popular book by Dr. Paul Krawitz - now available as a FREE DOWNLOAD. Includes AREDS2 study results and explanations, the 'Ultimate Insider's Guide to Eye Health" contains critical information about common eye problems, including macular degeneration, dry eye syndrome, cataract surgery, diabetic retinopathy, and contact lenses.

Get this ebook now